Immunomedics (NASDAQ: IMMU) reported Q2 EPS of ($0.02), versus ($0.23) reported last year. Revenue for the quarter came in at $600 thousand, versus $40 thousand reported last year.

For earnings history and earnings-related data on Immunomedics (IMMU) click here.